A Phase II Study of Glofitamab for Relapsed/Refractory Mantle Cell Lymphoma in Patients Previously Treated With CD19-Directed CAR T-Cell Therapy
Latest Information Update: 10 Jun 2025
At a glance
- Drugs Glofitamab (Primary) ; Obinutuzumab (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
Most Recent Events
- 10 Jun 2025 New trial record